Zacks Investment Research · 21 Sept 2026neutral
Zacks Investment Research published an article on FitLife Brands (FTLF), explaining that its focus is on the Zacks Rank system, which emphasises earnings estimates and estimate revisions, while also monitoring value, growth, and momentum trends to identify strong picks.
Why it matters — The piece indicates that FitLife Brands is being evaluated through Zacks' stock-rating framework, which FTLF watchers may follow for potential rating-driven coverage.
Zacks Investment Research · 3 Sept 2026neutral
Zacks Investment Research published a piece examining whether value investors should consider FitLife Brands (FTLF) stock. The article notes that Zacks focuses on its Zacks Rank system, which emphasizes earnings estimates and estimate revisions, while also tracking value, growth, and momentum trends.
Why it matters — FTLF watchers would care because the piece evaluates the stock within Zacks' analytical framework, which could inform how the company is assessed by a major research firm.
Zacks Investment Research · 18 Aug 2026positive
FitLife Brands (FTLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting increased optimism about the company's earnings prospects.
Why it matters — The upgrade signals growing confidence in FitLife Brands' earnings potential, which could influence how the market views the stock.
Zacks Investment Research · 18 Aug 2026neutral
Zacks Investment Research published an article examining whether investors are undervaluing FitLife Brands (FTLF). The piece highlights the firm's Zacks Rank system, which focuses on earnings estimates and estimate revisions, while also considering value, growth, and momentum trends to identify strong stock picks.
Why it matters — FTLF watchers would care because the article assesses the stock's valuation and positioning through Zacks' earnings-estimate and trend-based screening framework.
MarketBeat · 14 Aug 2026positive
FitLife Brands reported second-quarter 2026 revenue of $26.5 million, up 65% year over year, driven by the acquisition of Irwin Naturals, while net income rose to $2.0 million and adjusted EBITDA increased 10% to $3.7 million.
Why it matters — The results show that the Irwin Naturals acquisition is significantly boosting revenue and profitability, offsetting weakness in the company's legacy business.